Functional copy number changes in Sézary syndrome: toward an integrated molecular cytogenetic map III

Cancer Genetics and Cytogenetics

Volumn 185, Issue 2, 2008, Pages 86-94

  Mao, Xin ^a   McElwaine, Suzanne ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER PATIENT; CHROMOSOME 15Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 6Q; CHROMOSOME MAP; COMPUTER PROGRAM; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCATION; HUMAN; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEZARY SYNDROME; UNINDEXED SEQUENCE;

CHROMOSOME MAPPING; GENE EXPRESSION PROFILING; HUMANS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEZARY SYNDROME;

EID: 49649094211     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.05.006     Document Type: Article

References (48)

1. Lutzner M., Edelson R., Schein P., Green I., Kirkpatrick C., and Ahmed A. Cutaneous T-cell lymphomas: The Sézary syndrome, mycosis fungoides and related disorders. Ann Int Med 83 (1975) 534-552
2. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., Ralfkiaer E., Chimenti S., Diaz-Peréz J.L., Duncan L.M., Grange F., Harris N.L., Kempf W., Kerl H., Kurrr M., Knobler R., Pimpinelli N., Sander C., Santucci M., Sterry W., Vermeer M.H., Wechsler J., Whittaker S., and Meijer C.J. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
3. Weiss L.M., Hu E., Wood G.S., Moulds C., Cleary M.L., Warnke R., and Sklar J. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermopathic lymph nodes. N Engl J Med 313 (1985) 539-544
4. Whittaker S.J., Smith N.P., Russell-Jones R., and Luzzatto L. Analysis of beta, gamma and delta T-cell receptor genes in mycosis fungoides and Sézary syndrome. Cancer 68 (1991) 1572-1582
5. Willemze R., Kerl H., Sterry W., Berti E., Cerroni L., Chimenti S., Diaz-Peréz J.L., Geerts M.L., Goos M., Knobler R., Ralfkiaer E., Santucci M., Smith N., Wechsler J., van Vloten W.A., and Meijer C.J. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 (1997) 354-371
6. Thangavelu M., Finn W.G., Yelavarthi K.K., Roenigk Jr. H.H., Samuelson E., Peterson L., Kuzel T.M., and Rosen S.T. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 89 (1997) 3371-3377
7. Karenko L., Hyytinen E., Sarna S., and Ranki A. Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 108 (1997) 22-29
8. Karenko L., Kahkonen M., Hyytinen E.R., Lindlof M., and Ranki A. Notable losses at specific regions of chromosomes 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization. J Invest Dermatol 112 (1999) 392-395
9. Mao X., Lillington D., Scarisbrick J., Mitchell T., Czepulkowski B., Russell-Jones R., Young B., and Whittaker S. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 147 (2002) 464-545
10. Mao X., Lillington D., Czepulkowski B., Russell-Jones R., Young B., and Whittaker S. Molecular cytogenetic characterisation of Sezary syndrome. Genes Chromosomes Cancer 36 (2003) 250-260
11. Mao X., Orchard G., Lillington D., Russell-Jones R., Young B., and Whittaker S. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101 (2003) 1513-1519
12. Fischer T.C., Gellrich S., Muche J.M., Sherev T., Audring H., Neitzel H., Walden P., Sterry W., and Tönnies H. Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol 122 (2004) 579-586
13. Batista D.A., Vonderheid E.C., Hawkins A., Morsberger L., Long P., Murphy K.M., and Griffin C.A. Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities. Genes Chromosomes Cancer 45 (2006) 383-391
14. Mao X. Molecular cytogenetics of primary cutaneous lymphomas. [PhD Thesis. PhD degree awarded at King's College London, University of London on 27 Feb 2004].
15. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
16. Schena M., Shalon D., Heller R., Chai A., Brown P.O., and Davis R.W. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93 (1996) 10614-10619
17. DeRisi J., Penland L., Brown P.O., Bittner M.L., Meltzer P.S., Ray M., Chen Y., Su Y.A., and Trent J.M. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14 (1996) 457-460
18. Tracey L., Villuendas R., Ortiz P., Dopazo A., Spiteri I., Lombardia L., Rodríguez-Peralto J.L., Fernández-Herrera J., Hernández A., Fraga J., Dominguez O., Herrero J., Alonso M.A., Dopazo J., and Piris M.A. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 161 (2002) 1825-1837
19. Tracey L., Villuendas R., Dotor A.M., Spiteri I., Ortiz P., Garcia J.F., Peralto J.L., Lawler M., and Piris M.A. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 102 (2003) 1042-1050
20. Kari L., Loboda A., Nebozhyn M., Rook A.H., Vonderheid E.C., Nichols C., Virok D., Chang C., Horng W.H., Johnston J., Wysocka M., Showe M.K., and Showe L.C. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 197 (2003) 1477-1488
21. Mao X., Orchard G., Lillington D., Child F., Vonderheid E., Nowell P.C., Bagot M., Bensussan A., Russell-Jones R., Young B., and Whittaker S. BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 151 (2004) 546-556
22. Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH, Willemze R, Tensen CP, Young B, Whittaker S. A genomic and expression expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUND and JUNDB in mycosis fungoides and Sezary syndrome. J Cutan Pathol 2008; May 20 [Epub ahead of print].
23. van Doorn R., Dijkman R., Vermeer M.H., Out-Luiting J.J., van der Raaij-Helmer E.M., Willemze R., and Tensen C.P. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis. Cancer Res 64 (2004) 5578-5586
24. Hahtola S., Tuomela S., Elo L., Häkkinen T., Karenko L., Nedoszytko B., Heikkilä H., Saarialho-Kere U., Roszkiewicz J., Aittokallio T., Lahesmaa R., and Ranki A. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma. Clin Cancer Res 12 (2006) 4812-4821
25. Mao X., Zhao P., Hamoudi R., and Baudis M. Genetic losses in breast cancer: towards integrated molecular cytogenetic map. Cancer Genet Cytogenet 160 (2005) 141-151
26. Mao X., Hamoudi R., Talbot I.C., and Baudis M. Allele-specific loss of heterozygosity in multiple colorectal cancers: towards an integrated molecular cytogenetic map II. Cancer Genet Cytogenet 167 (2006) 1-14
27. Mao X., Orchard G., Vonderheid E., Nowell P.C., Bagot M., Bensussan A., Russell-Jones R., Young B., and Whittaker S. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-cell lymphomas suggesting the presence of tumour subclones with deregulated cell cycle control checkpoints. J Invest Dermatol 126 (2006) 1388-1395
28. Prochazkova M., Chevret E., Mainhaguiet G., Sobotka J., Vergier B., Belaud-Rotureau M.A., Beylot-Barry M., and Merlio J.P. Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer 46 (2007) 828-838
29. Vermeer M.H., van Doorn R., Dijkman R., Mao X., Whittaker S., van Voorst Vader P.C., Gerritsen R., Geerts M.L., Gellrich S., Out C., Knijnenburg J., Jszenga M.I., Szuhai K., Willemze R., and Tensen C.P. Array-based comparative genomic hybridisation reveals novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 68 (2008) 2689-2698
30. Brockdorff J., Nielsen M., Kaltoft K., Mustelin T., Röpke C., Svejaard A., Geisler C., and Odum N. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway. Eur Cytokine Netw 11 (2000) 225-231
31. Zhang C.L., Kamarashev J., Qin J.Z., Burg G., Dummer R., and Döbbeling U. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol 200 (2003) 249-254
32. Querfeld C., Rosen S.T., Guitart J., and Kuzel T.M. The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy. Curr Opin Hematol 12 (2005) 273-278
33. van Doorn R., Zoutman W.H., Dijkman R., de Menezes R.X., Commandeur S., Mulder A.A., van der Velden P.A., Vermeer M.H., Willemze R., Yan P.S., Huang T.H., and Tensen C.P. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 23 (2005) 3886-3896
34. Venkatesh T., and Harlow H.B. Integromics: challenges in data integration. Genome Biol 3 (2002) reports4027.1-reports4027.3
35. Weinstein J.N. Integromic analysis of the NCI-60 cancer cell lines. Breast Dis 19 (2004) 11-22
36. Bulyk M.L. Analysis of sequence specificities of DNA-binding proteins with protein binding microarrays. Methods Enzymol 410 (2006) 279-299
37. Bulyk M.L. Protein binding microarrays for the characterization of DNA-protein interactions. Adv Biochem Eng Biotechnol 104 (2007) 65-85
38. Beckmann J.S., Estivill X., and Antonarakis S.E. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 8 (2007) 639-646
39. McCarroll S.A., and Altshuler D.M. Copy-number variation and association studies of human disease. Nat Genet 39 (2007) S37-S42
40. Ropers H.H. New perspectives for the elucidation of genetic disorders. Am J Hum Genet 81 (2007) 199-207
41. Tycko B., Smith S.D., and Sklar J. Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia. J Exp Med 174 (1991) 867-873
42. Burnett R.C., Thirman M.J., Rowley J.D., and Diaz M.O. Molecular analysis of the T-cell acute lymphoblastic leukemia-associated t(1;7)(p34;q34) that fuses LCK and TCRB. Blood 84 (1994) 1232-1236
43. Mahadevan D., Spier C., Della Croce K., Miller S., George B., Riley C., Warner S., Grogan T.M., and Miller T.P. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol Cancer Ther 4 (2005) 1867-1879
44. Fargnoli M.C., Edelson R.L., Berger C.L., Chimenti S., Couture C., Mustelin T., and Halaban R. Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk. Leukemia 11 (1997) 1338-1346
45. Wotherspoon A.C., Pan L.X., Diss T.C., and Isaacson P.G. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 58 (1992) 35-38
46. Willis T.G., Jadayel D.M., Du M.Q., Peng H., Perry A.R., Abdul-Rauf M., Price H., Karran L., Majekodunmi O., Wlodarska I., Pan L., Crook T., Hamoudi R., Isaacson P.G., and Dyer M.J. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96 (1999) 35-45
47. Shen L., Liang A.C., Lu L., Au W.Y., Wong K.Y., Tin P.C., Chan K.W., Ko K.H., Chen Y.W., Beh S.L., Shimizu N., Tsuchiyama J., Tang J.C., Kwong Y.L., Liang R.H., and Srivastava G. Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma. Blood 102 (2003) 1553-1554
48. Samraj A.K., Stroh C., Fischer U., and Schulze-Osthoff K. The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression. Oncogene 25 (2006) 186-197